DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20161317

A comparative study of efficacy of misoprostol with methyl ergometrine and carboprost in active management of third stage of labour

Pradnya A. Supe, Shailesh J. Kore, Y. S. Nandanwar

Abstract


Background: To assess the efficacy and safety of Misoprostol 800ug per rectally in active management of third stage of labour.

Methods: In this prospective study, a total of 200 pregnant women who delivered after 34 weeks of gestation at a tertiary teaching institute were included. The women were divided in to 4 groups by using randomization depending on the drug given at birth of anterior shoulder. Group A were given 800ug of Misoprostol per rectally, Group B were given 0.2mg of methyl ergometrine, Group C were given 125ug of Carboprost and Group D was the control group. The duration of third stage of labor and the blood loss was calculated and the results of all four groups were compared.

Results: Out of 200 antenatal women, the average duration of third stage of labor was shortest in the misoprostol group (8.88 minutes).The reduction in blood loss was significant with misoprostol as compared to ergometrine (p=0.016) and carboprost (0.009).The difference in pre and post-delivery hemoglobin was also significantly significant with misoprostol as compared to methyl ergometrine (0.048), carboprost (0.0001) and control (0.006).

Conclusions: Misoprostol 800ug per rectally is an effective alternative in the active management of third stage of labor as compared to methyl ergometrine and carboprost.


Keywords


Third stage of labor, Misoprostol, Postpartum Hemorrhage

Full Text:

PDF

References


Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000(3).

Afolabi EO, Kuti O. Oral misoprostol versus intramuscular oxytocin in the active management of third stage of labour Singapore Med J. 2010;51(3):207-11.

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039-47.

Abalos E. Active versus expectant management of the third stage of labour: RHL commentary (last revised: 2 March 2009). The WHO Reproductive Health Library; Geneva: World Health Organization.

Nagaria T, Sahu B. 400ug oral Misoprostol versus 0.2mg intravenous Methyl ergometrine for the active management of the third stage of labour.J Obstet Gynacol India. 2009:59:228-34.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC. Obstetrical Hemorrhage, Williams Obstetrics , 23nd Edn. Philadelphia. McGraw Hill; 2010; pp 757-803.

Pritchard JA, Baldwin RM, Dickey JC, Wiggins KM. Blood volume changes in pregnancy and puerperium, II: red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. American Journal of Obstetrics and Gynecology. 1962;84:1271-82.

Joshi V, Sapre S, Jaiswal N, Olyai R.Comaparative study between per rectal misoprostol and IM methergin for prophylaxis of PPH. Obstet Gynecol Today. 2006;XI(3):160-2.

Gerstenfeld TS and Wing AD. Rectal misoprostal verses intravenous oxytocic for the prevention of post partum haemorrhage after vaginal delivery. (Am J. Obstet Gynecol. 2001;185:878-82.

Prata N, Hamza S, Gypson R. Misoprostol and active management of the third stage of labor Int.J Obstet Gynaecol. 2006:94:149-55.

Purushottam BJ, Patil R. Prophylactic intramuscular PGF2α versus intravenous methyl ergometrine for prevention of atonic PPH in high risk women J Obstet Gynaecol India. 2008:58:417-20.

Walley RL, Wilson J, Mathews K. A double blind placebo controlled trial of Misoprostol and Oxytocin in the management of third stage of labor Br J Obstet Gynaecol. 2000;107:1111-5.

WHO Multi Center randomized trial in the management of the third stage of labour. The Lancet. 2001;358:689-95.

Amant F, Spitz B, Corremans A. Misoprostol compared with methyle ergometerine for the prevention of PPH a double blind randomized trial. British Journal of Obstet and Gynecol. 1999;106:1066-70.

Hofmeyr GJ Gulmezoglu A. Metinnew developments in the management of post partum haemorrhage. In John Bonnar, Editor, Recent advances in Obstetrics and Gynecol 21st Edn. Ne Delhi; Harcourt Publishers Limited; 2001 pp 55-66.

Mansouri HA, Alsahly N, Rectal versus oral misoprostol for active management of third stage of labor : a randomized controlled trial , Arch Gynecol Obstet , 2011;283(5):935-9.